Biotechnology Value Trading Fund Os Lp - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Eledon Pharmaceuticals Inc (ELDN). Other recent insider transactions involving Eledon Pharmaceuticals Inc (ELDN) include a net purchase of 1,978,932 shares made by Biotechnology Value Fund L P ,

In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 1,978,932 shares were bought by its insiders, resulting in a net purchase of 1,978,932 shares.

Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in XOMA Corp (XOMA). Other recent insider transactions involving XOMA Corp (XOMA) include a net purchase of 9,100 shares made by Bradley Sitko , a net purchase of 5,500 shares made by Owen Hughes , and a net purchase of 22,249 shares made by Biotechnology Value Fund L P .

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMA) were sold and 36,849 shares were bought by its insiders, resulting in a net purchase of 36,849 shares.

XOMA Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Merus NV (MRUS). Other recent insider transactions involving Merus NV (MRUS) include a net sale of 1,683 shares made by Harry Shuman , and a net sale of 22,386 shares made by Peter B. Silverman .

In summary, during the past 3 months, insiders sold 0 shares of Merus NV (MRUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,069 shares of Merus NV (MRUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,069 shares.

Merus NV (MRUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 989,618 shares made by Bruce Booth , a net sale of 862,075 shares made by Atlas Venture Fund X, L.p. , and a net sale of 49,881 shares made by Jared Gollob .

In summary, during the past 3 months, insiders sold 836,832 shares of Kymera Therapeutics Inc (KYMR) in total and bought 0 shares, with a net sale of 836,832 shares. During the past 18 months, 1,927,748 shares of Kymera Therapeutics Inc (KYMR) were sold and 455,112 shares were bought by its insiders, resulting in a net sale of 1,472,636 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in IDEAYA Biosciences Inc (IDYA). Other recent insider transactions involving IDEAYA Biosciences Inc (IDYA) include a net sale of 38,970 shares made by Jason Throne , a net sale of 425,000 shares made by Yujiro S Hata , and a net sale of 10,000 shares made by Briseno Andres Ruiz .

In summary, during the past 3 months, insiders sold 203,500 shares of IDEAYA Biosciences Inc (IDYA) in total and bought 0 shares, with a net sale of 203,500 shares. During the past 18 months, 514,970 shares of IDEAYA Biosciences Inc (IDYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,970 shares.

IDEAYA Biosciences Inc (IDYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Calithera Biosciences Inc (CALA). Other recent insider transactions involving Calithera Biosciences Inc (CALA) include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in CTI BioPharma Corp (CTIC). Other recent insider transactions involving CTI BioPharma Corp (CTIC) include a net sale of 100,000 shares made by James K Fong , a net sale of 85,317 shares made by Adam R Craig , and a net sale of 54,042 shares made by David Kirske .

In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 239,359 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 239,359 shares.

CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 292,500 shares made by Robert I Blum , a net sale of 147,222 shares made by Fady Ibraham Malik , and a net sale of 27,186 shares made by John T Henderson .

In summary, during the past 3 months, insiders sold 76,725 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 76,725 shares. During the past 18 months, 530,177 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 530,177 shares.

Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 10,000 shares made by Christopher P Kiritsy ,

In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 125 shares were bought by its insiders, resulting in a net purchase of 125 shares.

Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net purchase of 2,026,717 shares made by Invus Public Equities, L.p. , a net sale of 4,121,511 shares made by Scott D Sandell , and a net purchase of 175,403 shares made by Edwin Rock .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,125,211 shares of GlycoMimetics Inc (GLYC) were sold and 2,245,620 shares were bought by its insiders, resulting in a net sale of 1,879,591 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Concert Pharmaceuticals Inc (CNCE). Other recent insider transactions involving Concert Pharmaceuticals Inc (CNCE) include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 12,999 shares made by James V Cassella , and a net sale of 11,386 shares made by Jeffrey A Munsie .

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc (CNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 61,104 shares of Concert Pharmaceuticals Inc (CNCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,104 shares.

Concert Pharmaceuticals Inc (CNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,

In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.

Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 369,983 shares made by Briggs Morrison , a net sale of 25,069 shares made by Peter Ordentlich , and a net sale of 83,000 shares made by William Meury .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 523,588 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 523,588 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 150,477 shares made by Simon N. Pimstone , a net sale of 26,576 shares made by Gary Patou , and a net sale of 31,655 shares made by Ian Mortimer .

In summary, during the past 3 months, insiders sold 22,229 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 22,229 shares. During the past 18 months, 256,637 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 256,637 shares.

Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Crispina Calsada , and a net sale of 5,468 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Alpine Immune Sciences Inc (ALPN). Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 19 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 19 shares. During the past 18 months, 3,587,529 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,529 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 55,496 shares made by Sean A. Mccarthy , a net sale of 16,868 shares made by Lloyd A Rowland , and a net sale of 16,235 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 47,819 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 47,819 shares. During the past 18 months, 121,072 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 116,072 shares.

CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 2,240 shares made by Daniel Calkins , a net sale of 39,211 shares made by Robert E. Gagnon , and a net sale of 41,587 shares made by Brian M Stuglik .

In summary, during the past 3 months, insiders sold 1,735 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 1,735 shares. During the past 18 months, 108,848 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,848 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , and a net sale of 995,000 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 203,445 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 308,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .

In summary, during the past 3 months, insiders sold 65,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 65,000 shares. During the past 18 months, 443,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,812,858 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 79,555 shares made by Jennifer Michaelson , a net sale of 6,823 shares made by Jeffrey Trigilio , and a net sale of 3,809 shares made by Jeffrey Alan Jones .

In summary, during the past 3 months, insiders sold 63,606 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 63,606 shares. During the past 18 months, 220,214 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 220,214 shares.

Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Repare Therapeutics Inc (RPTX). Other recent insider transactions involving Repare Therapeutics Inc (RPTX) include a net sale of 12,683 shares made by Michael Zinda , a net purchase of 2,011,010 shares made by Biotechnology Value Fund L P , and a net sale of 13,091 shares made by Lloyd Mitchell Segal .

In summary, during the past 3 months, insiders sold 21,690 shares of Repare Therapeutics Inc (RPTX) in total and bought 0 shares, with a net sale of 21,690 shares. During the past 18 months, 282,163 shares of Repare Therapeutics Inc (RPTX) were sold and 2,011,010 shares were bought by its insiders, resulting in a net purchase of 1,728,847 shares.

Repare Therapeutics Inc (RPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 1,629,151 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 0 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 35,137 shares made by Scott Bizily , a net sale of 340,847 shares made by David Kirn , and a net purchase of 310,000 shares made by Viking Global Investors Lp .

In summary, during the past 3 months, insiders sold 19,236 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 19,236 shares. During the past 18 months, 945,536 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 850,000 shares were bought by its insiders, resulting in a net sale of 95,536 shares.

4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in ESSA Pharma Inc (EPIX). Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 78,475 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net purchase of 33,657 shares made by David Ross Parkinson .

In summary, during the past 3 months, insiders sold 1,388 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 1,388 shares. During the past 18 months, 78,475 shares of ESSA Pharma Inc (EPIX) were sold and 133,387 shares were bought by its insiders, resulting in a net purchase of 54,912 shares.

ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in Third Harmonic Bio Inc (THRD). Other recent insider transactions involving Third Harmonic Bio Inc (THRD) include a net sale of 33,780 shares made by Natalie C. Holles , a net sale of 24,620 shares made by , and a net sale of 13,970 shares made by Julie Person .

In summary, during the past 3 months, insiders sold 59,507 shares of Third Harmonic Bio Inc (THRD) in total and bought 0 shares, with a net sale of 59,507 shares. During the past 18 months, 77,160 shares of Third Harmonic Bio Inc (THRD) were sold and 214,063 shares were bought by its insiders, resulting in a net purchase of 136,903 shares.

Third Harmonic Bio Inc (THRD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc (GPCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc (GPCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Structure Therapeutics Inc (GPCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Trading Fund Os Lp made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,

In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.

POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.